Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Vitamin D3 and parathyroid hormone-related peptide may have important uses in skin treatments.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Gender identity can be more diverse than just male or female.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

Plant extracts may help treat hormone-related hair loss.

New steroids were effective in blocking male hormone receptors in hamster prostates.